I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
2 Ergebnisse
1
Image_1_What Is the Most Suitable Agent Combined With Apati..:
Fuhai Hui
;
Chang Xu
;
Xiangbo Xu
...
doi:10.3389/fonc.2022.887332.s001. , 2022
Link:
https://doi.org/10.3389/fonc.2022.887332.s001
2
Image_1_What Is the Most Suitable Agent Combined With Apati..:
Fuhai Hui
;
Chang Xu
;
Xiangbo Xu
...
doi:10.3389/fonc.2022.887332.s001. , 2022
Link:
https://doi.org/10.3389/fonc.2022.887332.s001
RT Journal T1
Image_1_What Is the Most Suitable Agent Combined With Apatinib for Transarterial Chemoembolization Treatment in Advanced Hepatocellular Carcinoma Patients? A Systematic Review and Network Meta-analysis.png
UL https://suche.suub.uni-bremen.de/peid=base-ftfrontimediafig:oai:figshare.com:article_19860775&Exemplar=1&LAN=DE A1 Fuhai Hui A1 Chang Xu A1 Xiangbo Xu A1 Jiangxia Chen A1 Hefeng Geng A1 Chao Yang A1 Yingshi Zhang YR 2022 K1 Cancer K1 Cancer Cell Biology K1 Cancer Diagnosis K1 Cancer Genetics K1 Cancer Therapy (excl. Chemotherapy and Radiation Therapy) K1 Chemotherapy K1 Haematological Tumours K1 Molecular Targets K1 Radiation Therapy K1 Solid Tumours K1 Oncology and Carcinogenesis not elsewhere classified K1 transarterial chemoembolization (TACE) K1 apatinib K1 advanced hepatocellular carcinoma K1 systematic review K1 network meta-analysis JF doi:10.3389/fonc.2022.887332.s001 LK http://dx.doi.org/https://doi.org/10.3389/fonc.2022.887332.s001 DO https://doi.org/10.3389/fonc.2022.887332.s001 SF ELIB - SuUB Bremen RT Journal T1
Image_1_What Is the Most Suitable Agent Combined With Apatinib for Transarterial Chemoembolization Treatment in Advanced Hepatocellular Carcinoma Patients? A Systematic Review and Network Meta-analysis.png
UL https://suche.suub.uni-bremen.de/peid=base-ftfrontimediafig:oai:figshare.com:article_19860775&Exemplar=1&LAN=DE A1 Fuhai Hui A1 Chang Xu A1 Xiangbo Xu A1 Jiangxia Chen A1 Hefeng Geng A1 Chao Yang A1 Yingshi Zhang YR 2022 K1 Cancer K1 Cancer Cell Biology K1 Cancer Diagnosis K1 Cancer Genetics K1 Cancer Therapy (excl. Chemotherapy and Radiation Therapy) K1 Chemotherapy K1 Haematological Tumours K1 Molecular Targets K1 Radiation Therapy K1 Solid Tumours K1 Oncology and Carcinogenesis not elsewhere classified K1 transarterial chemoembolization (TACE) K1 apatinib K1 advanced hepatocellular carcinoma K1 systematic review K1 network meta-analysis JF doi:10.3389/fonc.2022.887332.s001 LK http://dx.doi.org/https://doi.org/10.3389/fonc.2022.887332.s001 DO https://doi.org/10.3389/fonc.2022.887332.s001 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)